Home › Funds › CROWN ADVISORS MANAGEMENT, INC. › AYTU

CROWN ADVISORS MANAGEMENT, INC. position in AYTU

AYTU BIOPHARMA INC · Health Care

CROWN ADVISORS MANAGEMENT, INC. reported holding 200,000 shares of AYTU (AYTU BIOPHARMA INC) in its Q3 2026 13F filing — a position valued at US$428K, representing 0.30% of its reported portfolio and ranking #42 among its reported holdings. CROWN ADVISORS MANAGEMENT, INC. has disclosed AYTU holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)200.00K sh
Reported value held$428.00K
Portfolio Weight0.30%
First reportedQ1 2026
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CROWN ADVISORS MANAGEMENT, INC.'s AYTU position evolved

CROWN ADVISORS MANAGEMENT, INC. first disclosed a stake in AYTU in Q1 2026 at 145,000 shares (US$395K). The position peaked in Q2 2026 at 200,000 shares, worth US$430K. Across 3 filings, CROWN ADVISORS MANAGEMENT, INC. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 200,000 shares valued at US$428K. Notable position changes include a 38% increase in Q2 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 145.00K $395.00K New
Q2 2026 200.00K $430.00K Add
Q3 2026 200.00K $428.00K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AYTU and 13F data

AYTU (AYTU BIOPHARMA INC) is a Health Care company. 28 other funds we track also report a position in AYTU — the largest reported positions include Stonepine Capital Management, LLC (US$2.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AYTU

All AYTU fund holders →

FAQ

How long has CROWN ADVISORS MANAGEMENT, INC. held AYTU?

CROWN ADVISORS MANAGEMENT, INC. has disclosed AYTU holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is CROWN ADVISORS MANAGEMENT, INC.'s current position in AYTU?

As of Q3 2026, CROWN ADVISORS MANAGEMENT, INC. holds 200.00K shares of AYTU (AYTU BIOPHARMA INC), valued at $428.00K, representing 0.30% of its reported portfolio and ranking #42.

Has CROWN ADVISORS MANAGEMENT, INC. been buying or selling AYTU?

In the latest 13F filing (Q3 2026), CROWN ADVISORS MANAGEMENT, INC. held unchanged its position in AYTU. The position peaked in Q2 2026 at 200.00K shares.

Which other funds hold AYTU?

Other major institutional holders of AYTU include Stonepine Capital Management, LLC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.